HIGH LEVELS OF CIRCULATING PLASMA CELLS ARE AN INDEPENDENT HIGH-RISK FEATURE IN MULTIPLE MYELOMA PATIENTS AND THEIR PROGNOSTIC IMPACT IS MODULATED BY THE ACHIEVEMENT OF MINIMAL RESIDUAL DISEASE NEGATIVITY

被引:0
作者
Bertamini, L. [1 ]
Stefanoni, P. [1 ]
Tacchetti, P. [1 ]
Ledda, A. [1 ]
Palmas, A. [1 ]
Gentile, M. [1 ]
Palmieri, S. [1 ]
Annibali, O. [1 ]
Musolino, C. [1 ]
Burdisso, M. [1 ]
Capra, A. [1 ]
Rizzi, R. [1 ]
Molica, S. [1 ]
Cellini, C. [1 ]
Monaco, F. [1 ]
De Sabbata, G. [1 ]
Cea, M. [1 ]
Rivolti, E. [1 ]
Fazio, F. [1 ]
Musto, P. [1 ]
Boccadoro, M. [1 ]
Gay, F. [1 ]
机构
[1] European Myeloma Network, Turin, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C008
引用
收藏
页码:12 / 13
页数:2
相关论文
共 50 条
[41]   Incidence and Prognostic Significance of High-Risk Cytogenetically Abnormalities in Multiple Myeloma Patients in Colombia [J].
Felipe Combariza, Juan ;
Orduz, Rocio ;
Agudelo, Claudia ;
Hernandez, Sonia ;
Maria Madera, Ana ;
Leon, Guillermo ;
Avila, Vladimir ;
Bautista, Leonardo ;
Valdes, Jaime ;
Camargo, Carlos ;
Sanchez, Victor ;
Mejia, Fabian ;
Moreno, Liliana ;
Ramirez, Carlos .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (08) :601-607
[42]   Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse [J].
Dhakal, Binod ;
Sharma, Shruti ;
Balcioglu, Mustafa ;
Shchegrova, Svetlana ;
Malhotra, Meenakshi ;
Zimmermann, Bernhard ;
Billings, Paul R. ;
Harrington, Alexandra ;
Sethi, Himanshu ;
Aleshin, Alexey ;
Hari, Parameswaran N. .
FRONTIERS IN ONCOLOGY, 2022, 12
[43]   Personalized, ctDNA analysis to detect minimal residual disease and identify patients at high risk of relapse with multiple myeloma. [J].
Dhakal, Binod ;
Sharma, Shruti ;
Shchegrova, Svetlana ;
Maninder, Minu ;
Malhotra, Meenakshi ;
Sethi, Himanshu ;
Zimmermann, Bernhard ;
Billings, Paul R. ;
Aleshin, Alexey ;
Hari, Parameswaran .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[44]   PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY AIMED AT VALIDATING A PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN HIGH-RISK NEUROBLASTOMA PATIENTS [J].
Nishimura, Noriyuki ;
Ishida, Toshiaki ;
Yokota, Isao ;
Matsumoto, Kimikazu ;
Shichino, Hiroyuki ;
Kamijo, Takehiko ;
Takimoto, Tetsuya ;
Iehara, Tomoko ;
Tajiri, Tatsuro .
PEDIATRIC BLOOD & CANCER, 2024, 71 :S13-S13
[45]   Quantitation of Minimal Residual Disease by Droplet Digital PCR in High-Risk Neuroblastoma Patients [J].
Nishimura, Noriyuki ;
Ishida, Toshiaki ;
Thwin, Khin ;
Uemura, Suguru ;
Yamamoto, Nobuyuki ;
Tamura, Akihiro ;
Nino, Nanako ;
Kozaki, Aiko ;
Saito, Atsuro ;
Kishimoto, Kenji ;
Hasegawa, Daiichiro ;
Kosaka, Yoshiyuki ;
Takafuji, Satoru ;
Mori, Takeshi ;
Iijima, Kazumoto .
PEDIATRIC BLOOD & CANCER, 2018, 65 :S38-S39
[46]   Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy [J].
Tschautscher, Marcella A. ;
Jevremovic, Dragan ;
Rajkumar, Vincent ;
Dispenzieri, Angela ;
Lacy, Martha Q. ;
Gertz, Morie A. ;
Buadi, Francis K. ;
Dingli, David ;
Hwa, Yi L. ;
Fonder, Amie L. ;
Hobbs, Miriam A. ;
Hayman, Suzanne R. ;
Zeldenrust, Steven R. ;
Lust, John A. ;
Russell, Stephen J. ;
Leung, Nelson ;
Kapoor, Prashant ;
Go, Ronald S. ;
Lin, Yi ;
Gonsalves, Wilson I. ;
Kourelis, Taxiarchis ;
Warsame, Rahma ;
Kyle, Robert A. ;
Kumar, Shaji K. .
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (07) :751-756
[47]   Clinical Significance and Transcriptional Profiling of Persistent Minimal Residual Disease (MRD) in Multiple Myeloma (MM) Patients with Standard-Risk (SR) and High-Risk (HR) Cytogenetics [J].
Goicoechea, Ibai ;
Puig, Noemi ;
Teresa Cedena, Maria ;
Cordon, Lourdes ;
Vidriales, Maria-Belen ;
Burgos, Leire ;
Flores-Montero, Juan ;
Gutierrez, Norma C. ;
Jose Calasanz, Maria ;
Luisa Martin-Ramos, Maria ;
Lara-Astiaso, David ;
Vilas-Zornoza, Amaia ;
Alignani, Diego ;
Rodriguez, Idoia ;
Sarvide, Sarai ;
Garcia-Sanz, Ramon ;
Martinez-Lopez, Joaquin ;
Oriol, Albert ;
Rios, Rafael ;
Martin, Jesus ;
Martinez, Rafael ;
Sarra, Josep ;
Hernandez, Miguel T. ;
De la Rubia, Javier ;
Krsnik, Isabel ;
Maria Moraleda, Jose ;
Palomera, Luis ;
Bargay, Joan ;
Orfao, Alberto ;
Rosinol, Laura ;
Mateos, Maria-Victoria ;
Jose Lahuerta, Juan ;
Blade, Joan ;
San-Miguel, Jesus F. ;
Paiva, Bruno .
BLOOD, 2018, 132
[48]   Genetic plasma cell signatures in high-risk smoldering myeloma versus multiple myeloma patients. [J].
Mailankody, Sham ;
Korde, Neha ;
Roschewski, Mark J. ;
Christofferson, Austin ;
Boateng, Martin ;
Zhang, Yong ;
Manasanch, Elisabet Esteve ;
Kazandjian, Dickran Gano ;
Kwok, Mary ;
Bhutani, Manisha ;
Tageja, Nishant ;
Zingone, Adriana ;
Costello, Rene ;
Lamy, Laurence ;
Hultcrantz, Malin ;
Papaemmanuil, Elli ;
Stetler-Stevenson, Maryalice ;
Figg, William Douglas ;
Keats, Jonathan J. ;
Landgren, Ola .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[49]   High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma [J].
Bertamini, Luca ;
Oliva, Stefania ;
Rota-Scalabrini, Delia ;
Paris, Laura ;
More, Sonia ;
Corradini, Paolo ;
Ledda, Antonio ;
Gentile, Massimo ;
De Sabbata, Giovanni ;
Pietrantuono, Giuseppe ;
Pascarella, Anna ;
Tosi, Patrizia ;
Curci, Paola ;
Gilestro, Milena ;
Capra, Andrea ;
Galieni, Piero ;
Pisani, Francesco ;
Annibali, Ombretta ;
Monaco, Federico ;
Liberati, Anna Marina ;
Palmieri, Salvatore ;
Luppi, Mario ;
Zambello, Renato ;
Fazio, Francesca ;
Belotti, Angelo ;
Tacchetti, Paola ;
Musto, Pellegrino ;
Boccadoro, Mario ;
Gay, Francesca .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (27) :3120-+
[50]   Enrichment of circulating myeloma cells by immunomagnetic beads combined with flow cytometry for monitoring minimal residual disease and relapse in patients with multiple myeloma [J].
Ningning Wang ;
Nahom Tesfaluul ;
Jia Li ;
Xiaojuan Gao ;
Shuai Liu ;
Baohong Yue .
Annals of Hematology, 2019, 98 :2769-2780